QA: Alpine Immune Sciences INC in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001626199_2022_Alpine_Immune_Sciences_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001626199, Alpine Immune Sciences INC

  xvar xval
0 AssetsCurrent 192,013,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,716,000
3 remainder_Assets 62,171,000
4 LiabilitiesCurrent 69,778,000
5 LiabilitiesNoncurrent 65,219,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 15,325,405
9 ResearchAndDevelopmentExpense 48,833,425
10 remainder_Expenses 745,498
11 remainder_Revenues 87,269,783
12 remainder_NetIncome 251,243
13 remainder_ComprehensiveNetIncome 2,717
  yvar yval
0 Assets 255,900,000
1 Liabilities 134,997,000
2 Expenses 64,904,328
3 Revenues 87,269,783
4 StockholdersEquity 120,903,000
5 NetIncome 22,616,698
6 ComprehensiveNetIncome 22,618,056
7 BaseVar 271,662,536
8 EconomicCapitalRatiobeforeLimitedLiability 1.46
9 EconomicCapitalRatio 2.65

Edgar->Model Mapping

Feature Distribution

Change over Time